UniQuest licenses IP to Organovo for kidney toxicity screening and drug development
UniQuest, the technology transfer company of The University of Queensland, has signed an exclusive worldwide licensing agreement with Organovo Holdings to patent applications relating to methodology for producing kidney cells from induced pluripotent stem cells. October 13, 2015